GI Dynamics, Inc., a medical device company, develops therapies for the treatment of type 2 diabetes and related metabolic diseases in the United States. Its products also include EndoBarrier, a non-surgical therapy to treat type 2 diabetes and obesity. The company was founded in 2003 and is based in Lexington, Massachusetts.

Recent Milestones
edit

GI Dynamics — received approval in Australia by the Therapeutic Goods Administration (TGA) to use its EndoBarrier Gastrointestinal Liner for the treatment of Type 2 Diabetes and obesity (7/25/11)

Posted 7/25/11 at 8:40am via masshightech.com
GI Dynamics received () in Venture Round funding. (1/7/10)

Posted 1/7/10 at 9:12pm via finsmes.com
GI Dynamics added Stuart A. Randle as President & CEO.

Posted 1/7/10 at 9:12pm
GI Dynamics added Andy Levine as CTO.

Posted 1/7/10 at 9:12pm
GI Dynamics added Robert Crane as CFO.

Posted 1/7/10 at 9:12pm